Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Veru (FMW0) Drug Pipeline

3 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Enobosarm, Semaglutide Weekly InjectionObesity & Overweight, Mobility Disability, Homa-IrPhase IINot Yet RecruitingProof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossFeb 25, 2026―
Semaglutide, EnobosarmObesity, Muscle LossPhase IICompletedDose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight MgmtFeb 20, 2024
Sabizabulin, Exemestane Monotherapy, Exemestane Plus Everolimus, Or Selective Estrogen Receptor ModulatorMetastatic Breast CancerPhase IIWithdrawnEfficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerOct 01, 2021―
Enobosarm & Abemaciclib Combo, Non-Steroidal Ai, Or Steroidal Ai Or FulvestrantMetastatic Breast CancerPhase IIITerminatedEfficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerSep 21, 2021―
Sacituzumab Govitecan-Hziy, Sabizabulin, Sabizabulin/Sacituzumab Govitecan-Hziy ComboMetastatic Triple Negative Breast CancerPhase IIWithdrawnP2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .Aug 10, 2021―
Exemestane, EnobosarmMetastatic Breast CancerPhase IIITerminatedEfficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerApr 27, 2021―
Veru-111Sars-Cov InfectionPhase IIICompletedVERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyApr 09, 2021―
Veru-100Advanced Prostate Adenocarcinomaphase1AndPhase2TerminatedTo Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerApr 09, 2021―
Veru-111, Enzalutamide, AbirateroneMetastatic Castration-Resistant Prostate Cancer, Androgen Resistant Prostatic CancerPhase IIITerminatedEfficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentApr 09, 2021―
Veru-111Respiratory Distress Syndrome, AdultPhase IICompletedCOVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111May 13, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Veru Inc (DE:FMW0) have in its pipeline
Veru DE:FMW0 is currently developing the following drugs: Enobosarm, Semaglutide Weekly Injection, Semaglutide, Enobosarm, Sabizabulin, Exemestane Monotherapy, Exemestane Plus Everolimus, Or Selective Estrogen Receptor Modulator, Enobosarm & Abemaciclib Combo, Non-Steroidal Ai, Or Steroidal Ai Or Fulvestrant, Sacituzumab Govitecan-Hziy, Sabizabulin, Sabizabulin/Sacituzumab Govitecan-Hziy Combo, Exemestane, Enobosarm, Veru-111, Veru-100, Veru-111, Enzalutamide, Abiraterone, Veru-944. These drug candidates are in various stages of clinical development as the company works toward FDA approval.